Table 2. Expression levels of the five miRNAs in the peripheral plasma in the training and testing stages (presented as mean ± SD; fmol/L).
| miRNA | Training stage |
Testing stage |
Combined |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Controls | Cases | FC | P value | Controls | Cases | FC | P value | FC | P value | |
| miR-185 | 80.8 ± 40.1 | 138 ± 54.8 | 1.70 | 0.006 | 74 ± 34.1 | 122 ± 92.1 | 1.65 | 0.016 | 1.82 | <0.001 |
| miR-20a | 3248 ± 1860 | 5880 ± 2153 | 1.81 | <0.001 | 3098 ± 1801 | 5816 ± 4893 | 1.88 | 0.025 | 2.05 | <0.001 |
| miR-210 | 14.8 ± 4.54 | 35.5 ± 17.9 | 2.39 | <0.001 | 15.5 ± 6.1 | 35.4 ± 26.4 | 2.28 | <0.001 | 2.39 | <0.001 |
| miR-25 | 590 ± 317 | 980 ± 382 | 1.66 | 0.001 | 1011 ± 612 | 1719 ± 1218 | 1.70 | 0.002 | 1.70 | <0.001 |
| miR-92b | 18.6 ± 7.6 | 35.5 ± 16.7 | 1.90 | 0.006 | 14.1 ± 7 | 24.2 ± 14.7 | 1.71 | <0.001 | 1.74 | <0.001 |
FC: fold change.